CVS Health Corporation (CVS) stock forecasts

Summary

Nasdaq, we have a problem. Stocks have started the year on a rough slide — and the move after a nonfarm payrolls report blew away expectations (a near-term Fed stimulus may be a fading dream) was particularly dire. Now, insiders weigh in. And ugh. The one-week sell/buy ratio for the NYSE has broken into negative territory, at 6.25, slightly above 6.00 over the period. Last week the ratio was 3.38. That’s not great, but it’s only been a week (so far). But the Nasdaq’s one-week ratio has moved into negative territory since last week — and that’s where we notice, as the current ratio is an eye-popping 15.57, compared to last week’s 4.54. That’s a pretty ugly number in any case, but we’d hate to see it with only insiders barred from trading for weeks, especially as earnings season begins. Indeed, these ratios are not the ‘final word’ we seek from corporate executives, directors and beneficial owners. By sector, insider buying was the highest in the industry sector last week, with $3.4 million worth of shares traded compared to $5.9 million for a sell/buy ratio of 1.8. The sell/buy ratio was also high in financials.